Dr. Florian Kainzinger
Managing Partner & Founder @ Think.Health
Berlin, Germany
Dr. Florian Kainzinger is a Series B investor at Think.Health in Berlin focused on Medical and Health Care. Florian Kainzinger has more than 14 years of experience in health care management positions. He was Chief Executive Officer (CEO) of Labor Berlin between 2011 and 2015 with responsibility for more than 500 employees on 12 sites in Berlin. Prior to joining the lab organization of Charité and Vivantes, Florian used to work for Roland Berger StrategyConsultants, serving hospitals and pharmaceutical clients in Germany and Europe.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Dr. Florian Kainzinger invests in
Stages Dr. Florian Kainzinger invests in
Countries Dr. Florian Kainzinger invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (50%)
- Health Care 1 (50%)
- Biotechnology 1 (50%)
- Medical Device 1 (50%)
Stage
- Series B 1 (50%)
- Series C 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| SphingoTec is a biomaker company that develops and markets in vitro diagnostic solutions for novel and proprietary blood-based protein biomarkers. They also develop microtiter plates, which are a standard tool in analytical research and diagnostic testing laboratories. They develop biomakers to address diagnostically underserved critical careconditions such as acute kidney injury, sepsis, and acute heart failure. | $5.5M / Series C / Aug 08, 2024 | ||
| Spindiag provides an easy-to-use, compact, and automated point-of-care system for the broad, fast, and affordable detection of pathogens. It's first product is an automated SARS-CoV-2 test. Spindiag one can be operated with an easy to use and routine-compatible workflow by a nurse. Test results are directly transferred into the patient record.The patented centrifugal-microfluidic test system rapidly provides laboratory-grade PCR results directly from standard patient swab samples. SpinDiag works with your standard Copan ESwab® and allows culture confirmation or other lab tests without the necessity to take a second sample. The complete workflow is fully automated and suitable for operation by ward nurses. It features an ultrafast and highly-sensitive polymerase chain reaction (PCR). | $17.9M / Series B / May 26, 2020 |
Co-Investors
About Think.Health
Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers,
Think.Health Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Dr. Florian Kainzinger
Managing Partner & Founder
|
|||
|
Rob Hamilton
Senior Vice President Of Sales
|
|||
Dr. Michael Ruoff
Partner
|
|||
Nils Bottler
Venture Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Dr. Florian Kainzinger invest in?
Dr. Florian Kainzinger invests primarily in Medical, Health Care and Biotechnology startups, most often at Series B and Series C stage. Most of the 2 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Dr. Florian Kainzinger?
Public channels for Dr. Florian Kainzinger include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Dr. Florian Kainzinger last invest?
The most recent investment recorded for Dr. Florian Kainzinger closed in Aug 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
